Mathijs Bunck

Company: Eli Lilly & Company

Job title: Associate Vice President

Seminars:

The Next Wave of Therapeutics for CKD? Navigating Incretin-Based Therapies & the Kidney 8:00 am

• From pathogenesis to therapeutic intervention: incretin-based drugs and the kidney in type 2 diabetes • Developing incretin-based therapies for the treatment of kidney disease • Investigating the impact of multiple clinical comorbidities including cardiovascular diseases, NASH, and CKDRead more

day: Day One